Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI-4020 |
Trade Name | |
Synonyms | BI4020|BI 4020 |
Drug Descriptions |
BI-4020 is a 4th-generation EGFR inhibitor, with activity against EGFR T790M and C797S, which potentially inhibits tumor growth (PMID: 38396251). |
DrugClasses | EGFR Inhibitor 4th gen 16 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BI-4020 | BI-4020 | 0 | 0 |
BI-4020 + Panitumumab | BI-4020 Panitumumab | 0 | 0 |